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Ion exchange resins are cross-linked, water insoluble, 
polymer-carrying, ionisable functional groups. Drugs can 
be loaded onto the resins by an exchanging reaction, and 
hence, a drug-resin complex (drug resinate) is formed1. 
The drug is released from resinate by exchanging with 
ions in the gastrointestinal fluid, followed by drug 
diffusion. Being high molecular weight water insoluble 
polymers, the resins are not absorbed by the body and are 
therefore inert. IER have received considerable attention 
from pharmaceutical scientists because of their versatile 
properties as drug delivery vehicles. In past few years, 
IER have been extensively studied in the development of 
Novel drug delivery system and other biomedical 
applications. The use of IER has occupied an important 
place in the development of controlled- or sustained-
release systems because of their better drug-retaining 
properties and prevention of dose dumping. Research 
over the last few years has revealed that IER are equally 
suitable for drug delivery technologies, including 
controlled release, transdermal, nasal, topical and taste 
masking2. Synthetic ion exchange resins have been used 
in pharmacy and medicine for taste masking or 
controlled release of drug as early as 19503,4,5 . 
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IER are simply insoluble polyelectrolyte‟s that are 
insoluble polymers which contain ionizable groups 
distributed regularly along the polymer backbone. The 
most common resins used in formulations are cross-
linked polystyrene and polymethacrylate polymers. 
When IER are mixed with a fluid such as water, ions in 
the fluid can exchange with the polyelectrolyte‟s counter 
ions and be physically removed from the fluid. An ion 
exchange resin is a polymer (normally styrene) with 
electrically charged sites at which one ion may replace 
another. Natural soils contain solids with charged sites 
that exchange ions, and certain minerals called zeolites 
are quite good exchangers. Ion exchange also takes place 
in living materials because cell walls, cell membranes 
and other structures have charges. In natural waters and 
in wastewaters, there are often undesirable ions and some 
of them may be worth recovering. For example, 
cadmium ion is dangerous to health but is usually not 
present at concentrations that would justify recovery. On 
the other hand, silver ion in photographic wastes is not a 
serious hazard, but its value is quite high. In either case, 
it makes sense to substitute a suitable ion such as sodium 
for the ion in the wastewater. Synthetic ion exchange 
resins are usually cast as porous beads with considerable 
external and pore surface where ions can attach. The 
resins are prepared as spherical beads 0.5 to 1.0 mm in 
diameter. These appear solid even under the microscope, 
but on a molecular scale the structure is quite open (Fig. 
1). Whenever there is a great surface area, adsorption 
plays a role. If a substance is adsorbed to an ion 
exchange resin, no ion is liberated. Testing for ions in the 
effluent will distinguish between removal by adsorption 
and removal by ion exchange. Of course, both 
mechanisms may be significant in certain cases, and 
mass balances comparing moles removed with moles of 
ions liberated will quantify the amounts of adsorption 
and ion exchange 6. 
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ABSTRACT: 
Ion exchange resins are cross-linked water insoluble polymer-carrying, ionisable functional groups. IER have received 
considerable attention from pharmaceutical scientists because of their versatile properties as drug delivery vehicles. Research 
over the last few years has revealed that IER are equally suitable for drug delivery technologies, including controlled release, 
transdermal, nasal, topical and taste masking. The major drawback of sustained release of extended release or extended release 
is dose dumping, resulting in increased risk of toxicity. The use of IER has occupied an important place in the development of 
controlled- or sustained-release systems because of their better drug-retaining properties and prevention of dose dumping. 
Synthetic ion exchange resins have been used in pharmacy and medicine for taste masking or controlled release of drug. Drug 
resin complexation converts drug to amorphous form leading to improved drug dissolution. Several studies have reported the 
use of IER for drug delivery at the desired site of action. Sulfonated and carboxylic resins with a polystyrene backbone are 
most widely used in clinical medicine.  
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Commonly used for man-made ion exchange resins. 
These are: 
• -COOH, which is weakly ionized to -COO¯ 
• -SO3H, which is strongly ionized to -SO3¯ 
• -NH2, which weakly attracts protons to form NH3+ 
• -secondary and tertiary amines that also attract protons 
weakly 
• -NR3+, which has a strong, permanent charge (R stands 
for some organic   group) 
These groups are sufficient to allow selection of a resin 
with either weak or strong positive or negative charge. 
 
Figure 1:  Expanded view of polystyrene bead 
Classi f ication of IER (Ion Exchange Resins)
 
Ion exchange resins are broadly classified into two main 
categories, as cation exchange resins and anion exchange 
resins. 
1. Cation Exchange Resins:- whose exchangeable ions 
are positively charged: Cation exchange resins are 
prepared by the copolymerization of styrene and divinyl 
benzene and have sulfonic acid groups (-SO3H) 
introduced into most of the benzene rings. The 
mechanism of cation exchange process can be 
represented by the following reaction: 
Resin
-




 - -----Resin- -  C+  + ex+  
Where, Resin- indicates a polymer with SO3-sites 
available for bonding with exchangeable cation (ex+), 
and C+ indicates a cation in the surrounding solution 
getting exchanged. 
Cation exchange resins can be further classified into: 
A)  Strong Acid Cati on Exchange Resins  
Strong acid resins are so named because their chemical 
behaviour is similar to that of a strong acid. These resins 
are highly ionized in both the acid (R-SO3H) and salt 
(RSO3Na) form of the sulfonic acid group (-SO3H). They 
can convert a metal salt to the corresponding acid by the 
reaction: 
2(R-SO3 H) + NiCl2 - -- - -  (R-SO 4)  Ni + 2HCl 
The hydrogen and sodium forms of strong acid resins are 
highly dissociated, and the exchangeable Na+ and H+ are 
readily available for exchange over the entire pH range. 
Consequently, the exchange capacity of strong acid 
resins is independent of the solution pH. 
These resins would be used in the hydrogen form for 
complete deionization; they are used in the sodium form 
for water softening (calcium and magnesium removal). 
After exhaustion, the resin is converted back to the 
hydrogen form (regenerated) by contact with a strong 
acid solution, or the resin can be convened to the sodium 
form with a sodium chloride solution. For the above 
reaction, hydrochloric acid (HCl) regeneration would 
result in a concentrated nickel chloride (NiCl2) solution. 
B) Weak Acid Cation Exchange Resins  
These resins behave similarly to weak organic acids that 
are weakly dissociated. In a weak acid resin the ionizable 
group is a carboxylic acid (COOH) as opposed to the 
sulfonic acid group (SO3H ) used in strong acid resins. 
The degree of dissociation of a weak acid resin is 
strongly influenced by the solution pH. Consequently, 
resin capacity depends in part on the solution pH. A 
typical weak acid resin has limited capacity below a pH 
of 6.0, making it unsuitable for deionizing acidic metal 
finishing waste water. 
2.  Anion Exchange Resins: -  
Whose exchangeable ions are negatively charged: These 
are prepared by first chlormethylating the benzene rings 
of styrene-divinyl benzene copolymer to attach CH2Cl 
groups and then causing these to react with tertiary 
amines such as triethylamine. The mechanism of anion 








 - ---  Resin+-  A -  + ex -  
Where, Resin+ indicates a polymer with N+ sites 
available for bonding with exchangeable anion (ex-), and 
A- indicates cations in the surrounding solution getting 
exchanged. 
Anion exchange resins can be further classified into: 
A)  Strong Base Anion Exchange Resins  
Like strong acid resins, strong base resins are highly 
ionized and can be used over the entire pH range. These 
resins are used in the hydroxide (OH) form for water 
deionization. They will react with anions in solution and 
can convert an acid solution to pure water: 
R-NH 3 OH + HCl ------  R-NH 3 Cl + HOH 
Regeneration with concentrated sodium hydroxide 
(NaOH) converts the exhausted resin to the OH form 
(Jain, N.K, 2001) 
B) Weak Base Anion Exchange Resins  
Weak base resins are like weak acid resins in that the 
degree of ionization is strongly influenced by pH. 
Sharma et al                                         Journal of Drug Delivery & Therapeutics; 2014, 4(4), 115-123 117 
© 2011-14, JDDT. All Rights Reserved                                                 ISSN: 2250-1177                                               CODEN (USA): JDDTAO 
Consequently, weak base resins exhibit minimum 
exchange capacity above a pH of 7.0. The weak base 
resin does not have an OH ion form as does the strong 
base resin. 
R-NH 2  + HCl --------  R-NH 3 Cl 
Consequently, regeneration needs only to neutralize the 
absorbed acid; it need not provide OH ions. Less 
expensive weakly basic reagents such as ammonia (NH3) 
or sodium carbonate can be employed. 
 
Table  of  Types of  Ion Exchange Resins: -  
 
 
Figure 2: Classification of ion exchangers 
Selection of Suitable Ion Exchange Resin:  
The selection of IER for drug delivery applications is 
primarily governed by the functional-group properties of 
the IER7. However, the following points need to be 
considered during selection: 
• Capacity of the IER [i.e. the concentration of the 
exchangeable group in the  resin, usually expressed in 
mill equivalents per gram (meq g–1) of dry resin];  
• Degree of cross linking in the resin matrix;  
• Particle size of resin 
• Nature of drug and site of drug delivery. It is also 
important to evaluate the resin in the pH and ionic-
strength environment, simulating the in vivo situation; 
• Swelling ratio;  
• Biocompatibility and biodegradability;  
• Regulatory status of the IER. For example, a low 
degree of cross linking of the resin will facilitate the 
exchange of large ions, but it will also cause volume 
changes in the resin upon conversion from one form to 
another. Similarly, the use of a strong IER will give a 
rapid rate of exchange, but it could also cause hydrolysis 
of the labile drugs because strong IER are effective acid-
Type  Exchange 
species  
Polymer backbone  Commercial Resins  
Strong cation  -SO3H  
-SO3Na  
Polystyrene DVB 
Sodium Polystyrene  
Amberlite IR 120, Dowex 50, Indion 244, Purolite C100HMR, 
Kyron-T-154 Tulsion T-344, Amberlite IRP 69, Indion 254  




Amberlite IRC 50, Indion 204, Purolite C102DR, Kyron-T-104, 
Kyron-T-114, Doshion P544(R), Tulsion T-335 Tulsion T-339, 
Amberlite IRP88, Indion 234, Kyron-T-134  
Strong anion  N+R3  Polystyrene DVB  Amberlite IR 400, Dowex 1, Indion 454, Duolite AP 143  
Weak anion  N+R2  Polystyrene DVB  Amberlite IR 4B, Dowex 2  
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base catalysts. Therefore, a fine balance of all the 
parameters needs to be made to achieve optimal 
performance of drug-delivery systems (DDSs) containing 
IER.  
Characterization of IER 
As the performance of DDSs depends on the quality of 
IER, it is important to evaluate IER at each stage of the 
preparation of resinates. The following parameters are 
generally evaluated: 
 • Particle size – measured directly with a set of micro 
sieves by screening. The particle size of IER can also be 
determined by microscopy, Coulter counter9 and other 
available techniques. 
• Porosity – the porosity of dry IER can be determined 
through nitrogen adsorption at − 195°C, and by 
measuring the true density (mercury displacement)10. 
Scanning electron Microscopy reveals the internal pore 
structure. The use of an air-compression pycnometer for 
the determination of porosity has also been reported in 
the literature11. 
 • Moisture content – determined by Karl Fischer 
titrimetry. Excess water can be removed by drying in 
vacuum desiccators12.  
• IE capacity – the IE capacity of strong CER is 
determined as meq g–1 by evaluating the number of 
moles of Na+, which are absorbed by 1 g of the dry resin 
in the hydrogen form13,14. Similarly, the IE capacity of a 
strong basic AER is evaluated by measuring the amount 
of Cl− taken up by 1 g of the dry resin in the hydroxide 
form. 
Mechanism of binding of ion exchange resin with 
drugs:  
The principle property of resins is their capacity to 
exchange bound or insoluble ions with those in solution. 
Soluble ions may be removed from solution through 
exchange with the counter ions adsorbed on the resin as 
illustrated in equation 1 and 2.  
Re-S o3  –Na
+  + Drug+ - --  Re-S O3–Dru g
+  + Na +       
_______1  
Re-N (CH 3) -Cl
-  +Drug - _ _  Re-N (CH 3) -Dru g
-+Cl -
______2  
These exchanges are equilibrium reactions in which the 
extent of exchange is governed by the relative affinity of 
the resins for particular ions. Relative affinity between 
ions may be expressed as a selectivity co-efficient 
derived from mass action expression13 given in equation 
no. 3. 
KDM =
[D] R  [M]S 
[D]S [M]R 
 
Where,      [D] R = Drug concentration in resin  
                  [D]S = Drug concentration in the solution  
                  [M]S = Counter ion concentration in the 
solution  
                 [M]R = Counter ion concentration in the resin 
 Factors that influence selectivity include valency, 
hydrated size, pKa and the pH of the solutions. 
Borodkin et al. used selectivity coefficient to express the 
interaction of eleven amino drugs with potassium salt of 
polacrin, a polycarboxylic acid resin. When loading of 
resin with an ion of less affinity, the exchange may be 
driven towards the direction of unfavourable equilibrium 
by flooding the influence with high concentration or by 
using chromatographic column procedures.  
Resinate  preparation :   
Once the selection of a resin is made, the next step 
involves preparing its complex with drug, before 
designing a suitable delivery system. The main hurdle is 
to optimize the conditions of preparation, in order to 
obtain the desired drug loading in the resinates. 
 Generally, the following steps are involved in the 
preparation of resinates:  
• Purification of resin by washing with absolute ethanol, 
ethanol and water mixture16. Final washing with water 
removes all the impurities.  
• Changing the ionic form of IER might occasionally be 
required to convert a resin from one form to another, if it 
does not have the desired counter ions17. Strongly acidic 
CER are usually marketed in Na+ form and strongly 
basic AER in Cl− form. They are generally converted into 
hydrogen and hydroxide forms, respectively. The 
conversion can be achieved by soaking the resins with 
acid or alkali solutions, respectively. After changing the 
ionic form, the resin is subjected to washing with 
distilled water. 
1. Batch technique – after suitable pretreatment, a 
specific quantity of the granular IER is agitated with the 
drug solution until the equilibrium is established18 and;  
2. Column technique – resinate is formed by passing a 
concentrated solution of drug through the IER-packed 
column until the effluent concentration is the same as the 
eluent concentration.  
Drug release from IER:   
The rate and completeness of drug desorption in-vivo 
will be controlled by the diffusion rate of the drug 
through the polymer phase of the resin,(usually a 
function of molecular weight),the selectivity of the drug 
for the resin ,and the concentration of the electrolytes 
particularly in the hydrogen ion, in the desorption 
environment19.  
More hydrophobic drugs will usually elute from the resin 
at a lower rate, as will drugs with a relatively high 
selectivity for the carboxylic acid functional structure  
In the resin other resin-sorbate interactions are possible, 
and these can have a pronounced effect upon loading 
capacities and rates.  
An example of this might be the presence of the 
transition metal in the structure of the sorbate molecule 
which can result in considerable selectivity through the 
formation of a coordination compound with the resin.  
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Properties of IER: 
1. Exchange capacity: The capacity of an ion exchanger 
is a quantitative measure of its ability to take up 
exchangeable Counter-ions and refers to the number of 
ionic groups per unit weight or volume (meq per g or 
meq per mL). The weight-based value is generally much 
greater than the volume-based value since the resin is 
highly hydrated. However, in preparing drug– resinates, 
the actual capacity obtainable under specific 
experimental conditions would depend upon the 
accessibility of the functional groups for the drug of 
interest. The so-called „„available capacity‟‟ will be 
related to the drug physicochemical properties and will 
be inferior to the total capacity. The exchange capacity 
may limit the amount of drug that may be sorbed onto a 
resin and the potency of a drug–resin complex. Weak 
cation exchangers derived from acrylic acid polymers 
have higher exchange capacity (~10 meq/g) than the 
sulfonic acid (~4 meq/g) or amine resins because of 
bulkier ionic substituent‟s and the polystyrene matrix. 
Therefore, higher drug loads may often be achieved with 
the carboxylic acid resins
20
.  
2. Cross-linkage: The degree of cross-linking depends 
on the percent DVB used in the copolymerization. The 
Ion-exchange products available today are limited to a 
range of 2–16 wt% DVB. Below 2 wt%, the finished ion-
exchange materials lack the mechanical strength to resist 
the volume changes, which occur under normal 
operation. Above 16 wt%, the polymer structure resists 
swelling, so that production of a finished ion exchanger 
becomes difficult and costly. The amount of DVB 
determines the extent of swelling and shrinking of ion-
exchange resins. The swelling would affect the rate of 
hydration, the volume expansion of the resin in a 
column, the rate of exchange of ions, and the capacity of 
the resin to sorb large molecules. Even after sorption, 
some large molecules may be difficult to elute unless the 
DVB fraction is quite low. The excellent swelling 
properties of the ion-exchange resins, such as potassium 
salt of polymethacrylic acid resin (Amberlite IRP-88), 
has been practically used as a tablet disintegrating 
agent21,22.  
3. Ionization: In all ion exchangers, the ionization of the 
attached functional group is dependent on the Presence 
of water in the matrix. The amount of water that an ion-
exchange resin will imbibe, in turn, is dependent on the 
cross-linking of the polymer. The ionization of the 
functional group determines the type and the strength of 
an ion exchanger. In aqueous media, strong acid cation 
and strong base anion-exchange resins are fully hydrated; 
and the ions associated with the functional group are 
always free to exchange with ions of like charge in the 
solution being processed. However, the ionization in 
weak acid cation and weak base anion exchangers is 
different. The value at which ionization becomes 
effective (pKa value) in resins containing sulfonic, 
phosphoric or carboxylic acid exchange groups is <1, 2–
3, and 4–6, respectively. Anion exchangers with 
quaternary, tertiary, or secondary ammonium groups 
have apparent pKa values of >13, 7– 9, and 5– 9, 
respectively. The pKa value of a resin will have a 
significant influence on the drug release rate from the 
drug–resinate in the gastric fluids. 
 4. Particle size and form: The rate of ion exchange 
reaction depends on the size of the resin particles. 
Decreasing the size of the resin particles significantly 
decreases the time required for the reaction to reach 
equilibrium with the surrounding medium; hence larger 
particle size affords a slower release pattern20.  
5. Porosity and swelling: Porosity is defined as the ratio 
of volume of the material to its mass. The limiting size of 
the ions, which can penetrate into a resin matrix, depends 
strongly on the porosity. The porosity depends upon the 
amount of cross-linking substance used in 
polymerization method. The amount of swelling is 
directly proportional to the number of hydrophilic 
functional groups attached to the polymer matrix and is 
inversely proportional to the degree of DVB cross 
linking present in the resin23. 
 6. Stability: The ion exchange resins are inert 
substances at ordinary temperature and excluding the 
more potent oxidizing agents are resistant to 
decomposition through chemical attack. These materials 
are indestructible. They get degraded and degenerated in 
presence of gamma rays23.  
7. Purity and toxicity: It is necessary to establish the 
safety/toxicity of the ion-exchange resins because of very 
high fraction of the resin in drug–resin complex (>60%). 
Most commercial products cannot be used as such 
because they contain impurities that cause severe toxicity 
besides some pharmaceutical grade resins (Amberlite 
IRP series from Rohm&Haas).Therefore, a thorough 
purification of the resin is required to eliminate the 
impurities for the pharmaceutical application. Purified 
ion exchange resins are insoluble and nontoxic. 
However, administration of large enough quantities of 
ion-exchange resin may disturb the ion strength in the 
gastrointestinal fluids and cause harmful side effects24,25.  
8. Selectivity of resin for counter ion: Since ion 
exchange resin involves electrostatic forces, selectivity 
mainly depends on relative charge and ionic radius of 
hydrated ions competing for an exchange site and to 
some extent on hydrophobicity of competitor ion23. 
APPLICATION OF ION EXCHANGE RESINS 
 
(A) Pharmaceutical Application 
1) Sustained release formulations such as capsules, 
liquids, oral tablet, etc. Gastrointestinal sustained 
release mechanism:-Bioavailability of drug absorbed on 
ion exchange resins depends on both transits of the 
particles through the G.I. tract and drug release kinetic. 
Drug release or dissolution from the resin can in turn 
occurs only by replacement of the drug by another ion 
with the same charge. Since, the exchange is an 
equilibrium process, it depends on the body fluids, ionic 
constitution and fluid volume. Additionally release is not 
instantaneous, and the drug must diffuse through the 
resin from the internal exchange sites. The net result of 
all the phenomena is a sustained release system
5,6,32
.  
If the drug resin complex is administered orally a small 
amount of drug may be released. This would be followed 
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by significant and continuous release in the stomach 
where drug is exposed to high acid and chloride 
concentrations. Anionic exchange resins and strong 
cation exchangers release a limited amount of drug in the 
stomach as shown in Eq. 1& 2. 
Re-SO3 – Drug 
+ + H + Re-SO3 – H + + Drug 
+                 ----- 1 
Re-N (CH3)
+ Drug - + Cl - Re-N (CH3)+ Cl 
- + Drug - ----- 2 
In contrast drug bound to weakly acidic carboxylic acids 
released much more readily in the stomach as illustrated 
in Eq.3  
Re-COO - Drug + + H + Re-COOH + Drug + ------3 
The high effective pKa of the resin drives the 
equilibrium towards the formation of undissosiated acid 
in a low pH environment. This may promote rapid drug 
release. In the intestine the neutral pH should keep all 
ionic sites on the resins ionized and the exchange process 
should occur continuously. 
2) Taste masking (Chewable or Dispersible tablet of 
bitter drugs):-Certain drugs that have very bitter taste 
can be made relatively tasteless by adsorbing the drug on 
ion exchange resin although all the ion exchange resins 
can be useful for this purpose, the proper selection on 
ionic character of drug and release characteristics. Weak 
cation exchange resins can be used to formulate 
chewable or dispersible tablet of bitter drugs, for 
example Rodec decongestant tablet containing 
pseudoephedrin. Weak cation exchangers are most 
preferable for their ability to remain undissociated at 
alkaline pH of mouth, and thus masking the taste of 
bound drug and further releasing it rapidly at acidic pH 
of stomach. Avari and Bhalekar reported taste masking 
of highly bitter antibiotic, sparfloxacin with Indion 204 
weak cation exchanger. Resins have been used with 
success to prepare stable and tasteless dosage forms. 
Taste masking in chewable tablets having amino 
containing drugs like dextromethorphon, ephedrine, 
pseudoephedrine, etc. have been successfully carried out 
by using weak cation exchange resin33. 
 3) Chewing gum for buccal absorption:-Nicotine is a 
widely used patented product for smoking cessation 
program. It contains nicotine adsorbed on an ion 
exchange resin with carboxylic acid functionality and 
formulated in a flavored chewing gum base provides 
gradual drug release through buccal mucosa as the gum 
is chewed offering fresh saliva as solvent for elution 
 4) Bioadhesive system for treatment of gastric 
mucosa:-. Ion exchange resin may have inherent 
bioadhesive properties similar to those of highly charged 
polyanions.94 Hence ion exchange resins may be useful 
in mucoadhesive systems for topical treatment of 
stomach such as H. pylori infection for prolonging the 
gastric residence of amoxycillin and cimetidine. 
 5) Tablet Disintegration [Improved tablet 
Disintegration properties]:- Many tablets disintegrant 
owe their action to capacity to absorb water and swell up. 
Fine particle size ion exchange resins have shown 
superiority as disintegrating agent due to their 
considerable swelling pressure upon hydration. 
Advantages of ion exchange resins over conventional 
disintegrating agents are  
1. Rate of permeation of water and subsequent swelling 
is very fast and cut down the disintegration time.  
2. Ion exchange resins do not have adhesive tendency on 
hydration; hence tablet disintegrates evenly without 
formation of lumps.  
3. Ion exchange resin is effective in low concentration as 
disintegrants.  
4. Ion exchange resin incorporation confirms greater 
hardness to tablet.  
5. Ion exchange resin work equally efficiently with 
hydrophilic as well as hydrophobic formulations, 
especially with the later where the conventional 
disintegrant are ineffective.  
Because of their unusually large swelling capacities 
polymethacrylic carboxylic acid ion exchange resins 
have found usage in pharmacy as tablet disintegrants; for 
example pollacrilline a potassium salt of weakly acidic 
cation exchange resin with methacrylic acid divinyl 
benzene matrix35,36.  
Borodkin and Yunker investigated chances of 
interference of cation exchanger disintegrants with drug 
availability and assay. They concluded that such agents 
should not affect total in vivo availability. It was 
questionable, however, if any significant delay in 
absorption would occur. While assaying amine drugs 
buffers above 7 or below 3 or solutions with high cation 
concentration may be used to effect complete drug 
elution. 
 6) Targeted drug delivery system [Anticancer drug]:- 
This concept is based on the chemoembolished of drug-
loaded microspheres via the tumour arterial supply. 
Because of their physical size microspheres can be 
entrapped in the capillary beds along with their load of 
cytotoxic drugs can be delivered to well vascularised 
tumour tissues. B.N.gray has studied the in vitro release 
of cytotoxic agents from cytotoxic agents from ion 
exchange resins.  
7)  Cholesterol reducer:- Cholestyramine resin USP, 
when used as an active ingredient binds bile acids, this 
leads to replenishment of bile acids; through increased 
metabolism of serum cholesterol resulting in lowered 
serum cholesterol levels. 
8)  Improved dissolution of poorly soluble drugs:-The 
slow dissolution of poorly soluble drugs is well known 
problem responsible for poor bioavailability. The release 
rate of such drugs from resonates can be much quicker 
than the dissolution rate of the pure drug. Eg. 
Indomethacins which are soluble up to ca 6ppm in 
simulated gastric fluid, but are release very quickly from 
resinate. the commercially available product 
Indomethacin uses micronization of the drug powder to 
achieve rapid dissolution34. Not all poorly soluble drugs 
are amenable to micronization because of the problems 
including low melting point, dust formation and 
agglomeration.ion exchange resins are convenient 
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alternative. The rapid dissolution occurs due to two 
factors: 
1. Each individual molecule is bound to a functional site-
there is no crystal lattice energy to overcome.  
2. The ion exchange materials are relatively hydrophilic 
and so allow water and aqueous solutions easy access in 
to the 3-dimensional structure- eliminating problems 
with „wetting-out' the drug.  However this technique like 
micronization increases the rate of dissolution. It does 
not increase the solubility of the drug.  
9) Anti-deliquescence: Deliquescence is the property of 
a solid whereby it absorbs so much water that it dissolves 
in the water it absorbs. This problem is very difficult to 
solve, and requires the use of specialized equipments or 
careful scheduling of a production in dry seasons6. A 
very recent discovery by Rohm and Hass research 
laboratories show that using resinates can eliminate 
deliquescence during manufacturing and storage. Rohm 
and Hass have filed the patent application for it. They 
have found that resonates of deliquescent and highly 
hygroscopic drug retain the properties of the resin and 
are not deliquescent and remain free flowing powders. 
Their water absorption characteristics are similar to those 
of unloaded resin. so, that any formulation equipment 
that can handle the resin can handle the resinate of the 
deliquescent drug without need for special 
manufacturing conditions. For example sodium valproate 
is a drug which is well known to be highly deliquescent. 
However they have found that valproate resinates remain 
free-flowing even after exposure to ambient air.  
10) Polymorphism: Unlike deliquescence, 
polymorphism is a very common problem in 
pharmaceutical industry and huge sums of money are 
spent trying to identify polymorphs and trying to make 
stable, suitably soluble forms6. Failure to resolve such 
problems can result in significant stability problems for 
the final dosage form. Ion exchange resin presents a 
unique way to deal with the problem. a drug resinate is 
an amorphous solid that cannot crystallize or even form 
hydrates. In addition the release of the drug from the 
resinate is independent of the crystal form that was used 
to make it. Consequently using resinates completely 
eliminate any problem with polymorphism. 
(B) Drug Delivery Applications 
1. Oral drug delivery  
The major drawback of sustained release or extended 
release is dose dumping hence resulting in increased risk 
of toxicity. The use of IER has occupied an important 
place in the development of controlled or sustained-
release systems due of their better drug retaining 
properties and prevention of dose dumping. The drug 
resinates can also be used as a drug reservoir, which has 
caused a change of the drug release in hydrophilic 
polymer tablet2. The use of ion exchange resins into drug 
delivery systems have been encouraged because of their 
physicochemical stability, inert nature, uniform size, 
spherical shape assisting coating and equilibrium driven 
reproducible drug release in ionic environment2.  
2. Nasal drug delivery 
 
A novel nasal formulation, in the form of a nicotine-
Amberlite resin complex powder, has been developed 
that provided an optimal combined pulsatile and 
sustained plasma nicotine profile for smoking cessation. 
Amberlite IRP69 and Amberlite IR120 are similar 
cationic exchange materials with the same ion exchange 
capacity but due to a smaller particle size range (10-150 
μm). Amberlite IRP69 had a better flow property and a 
better adsorptive capacity than Amberlite IR120. The 
nicotine plasma profiles demonstrated that an initial 
rapid peak plasma level of nicotine followed by a 
sustained elevated level could be achieved by adjusting 
the ratio of free to bound nicotine in the Amberlite 
powder formulation31. 
3. Transdermal drug delivery  
IER are also involved in the formulation of transdermal 
drug delivery systems. The release rates of ketoprofen 
from the carbopol-based gel vehicles containing ion 
exchange fibers to which the ketoprofen had been bound 
were determined across 0.22 μm microporous membrane. 
The fluctuation of the release rate of ketoprofen from the 
vehicles was much lower compared with that of simple 
gels, though the cumulative amount of ketoprofen 
delivery was less. In addition ions could increase the rate 
and extent of ketoprofen delivery31.  
4. Ophthalmic drug delivery  
IER also find application in ophthalamic drug delivery 
systems. An example is Betoptic S which is a sterile 
ophthalmic suspension and it contains 0.25% betaxolol 
hydrochloride. It is a cardio selective beta-adrenergic 
receptor blocking agent manufactured by Alcon 
Laboratories in the US. It is an ocular resinate 
ophthalmic product designed to lower elevated 
intraocular pressure. The drug resinate complex is 
formed when the positively charged drug is bound to a 
cation ion-exchange resin (Amberlite1 IRP 69). The 
0.25% ophthalmic suspension of the drug showed an 
increased bioavailability31-33 . 
(C) Diagnostic and therapeutic applications  
Synthetic as well as natural polysaccharides based on 
ion-exchange resins have been used with good results for 
diagnostic determinations. eg. In gastric acidity. They 
have also found applications as adsorbents of toxins, as 
antacids, and as bile acid binding agents. Ion-exchange 
resins have been successfully used therapeutic in the 
treatment of liver diseases, renal insufficiency, urolithic 
disease and occupational skin disease. For instance, 
sodium polystyrene sulfonate is a sulfonic cation-
exchange resin used in the treatment of hyperkalemia 
and also used in acute renal failure. Phenteramine, a 
sympathomimetic amine is indicated for short term use 
in the management of exogeneous obesity in a regimen 
of weight reduction utilizing caloric restriction. It also 
has application in the control of cholesterol and 
potassium ion levels5, 20. 
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Marketed Ion Exchange Resin as Taste Masking Agent
26-30 
Weak Cation Exchangers  
Product name 
(Resin)  






Examples of Drugs  
Amberlite 
IRP64  
Methacrylic  -coo-  H+  10meq/kg  Spiramycin, ranitidine, 
dextromethorphan, Dimenhydrinate.  
Amberlite 
IRP88  
Methacrylic  -coo-  K+  -  Talampicillin HCl, paroxetine, beta-
lactum antibiotics  
Tulsion 335  Methacrylic  -coo-  H+  10meq/g  Norfloxacin, ofloxacin, 
roxithromycin  
Tulsion 339  Methacrylic  -coo-  K+  -  Chloroquine phosphate, quinine 
sulphate, ciprofloxacin, paracetamol  
Kyron-T-104  Methacrylic  -coo-  H+  -  Cefuroxime Axetil, Cefpodoxime 
Proxetil, Norfloxacin  
Kyron-T-114  Methacrylic  -coo-  H+  -  ItoprideHCl, Ofloxacin, Tramadol 
HCl  
Indion 204  Crosslinked 
polyacrylic  
-coo-  H+  10meq/g  Norfloxacin, ofloxacin, Famotidine, 
roxithromycin, dicyclomine HCl,  
Indion 214  Crosslinked 
polyacrylic  
-coo-  H+  10meq/g  Azithromycin  
Indion 234  Crosslinked 
polyacrylic  
-coo-  K+  -  Ciprofloxacin, chloroquine 
phosphate  
Indion 464  Crosslinked 
polymethacrylic  
-coo-  H+  9.5meq/g  Nicotine taste masking  
Kyron-T-134  Crosslinked 
polyacrylic  
-coo-  K+  -  Amodiaquine HCl,Cetirizine Di 
HCl, ChloroquinePhosphate  
Cefaclor Metronidazol  
Purolite 
C102DR  
Methacrylic  -coo-  H+  -  cardio-tonics and anti- depressants  
Doshion P544  Methacrylic  -coo-  H+  -  Roxithromycin  
 
 Strong Cation Exchangers 
Product name  Matrix  Functional 
group  
Standard 
ionic form  
Exchange 
capacity  
Examples of Drugs  
Amberlite IRP69  Styrene DVB  -SO3H  Na+  4.3 eq/kg  ranitidine  
Tulsion 344  Styrene DVB  -SO3H  Na+  -  Dextromethorphan, 
dicyclomine HCl  
Kyron-T-154  Styrene DVB  -SO3H  Na+  -  Erythromycin Stearate  
 
Strong Anion Exchanger 
Product name  Matrix  Functional group  Standard ionic form  Exchange capacity  Examples of Drugs  
Indion 454  Crosslinked 
polystyrene       
N+R3 Cl   
 
CONCLUSION  
IERs have been used in pharmacy and medicine for 
various functions, which include tablet disintegration, 
bioadhesive systems, sustained release systems. In recent 
years IER have been successfully utilized for masking of 
taste of bitter drugs.IER play a major role in the 
modification of drug release by forming a complex with 
drug substances. This article has attempted to review the 
literature bring to light the chemistry, properties, method 
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